Back to Walleye Capital LLC Walleye Capital LLC

REGNREGN
Showing 8 of 24 quarters

Position history for Walleye Capital LLCWalleye Capital LLC's holdings in REGENERON PHARMACEUTICALS

Walleye Capital LLC holds 22,596 shares of REGN (REGENERON PHARMACEUTICALS), worth $14.1M as of 2026-Q2. The position was increased (+461.8% shares). REGN represents 0.1% of Walleye Capital LLC's portfolio.

Current Value

$14.1M

Current Shares

22,596

Total Value Change

+$6.5M

Total Shares Change

+15,329

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
22,596
+461.8%
$14.1M0.1%$623.54
45
2026-Q1
Decreased
4,022
-88.7%
$3.1M0.0%$766.66
0
2025-Q4
Decreased
35,500
-59.4%
$27.4M0.1%$773.94
0
2025-Q3
Increased
87,474
+41.6%
$49.2M0.2%$560.05
47
2025-Q2
Increased
61,771
+653.7%
$32.4M0.1%$519.56
56
2025-Q1
Decreased
8,196
-18.6%
$5.2M0.0%$634.66
0
2024-Q4
Increased
10,074
+38.6%
$7.2M0.0%$698.71
36
2024-Q3
Increased
7,267
+48.3%
$7.6M0.0%$1,036.94
38

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used